Detalhe da pesquisa
1.
Deletion of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Accelerates Atherosclerosis Regression and Increases C-C Chemokine Receptor Type 7 (CCR7) Expression in Plaque Macrophages.
Circulation
; 138(17): 1850-1863, 2018 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29794082
2.
PCSK9 Association With Lipoprotein(a).
Circ Res
; 119(1): 29-35, 2016 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-27121620
3.
Loss of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 Confers Resistance to the Antiatherogenic Effects of Tumor Necrosis Factor-α Inhibition.
Arterioscler Thromb Vasc Biol
; 36(8): 1483-95, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27365402
4.
Local effects of human PCSK9 on the atherosclerotic lesion.
J Pathol
; 238(1): 52-62, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26333678
5.
Macrophage apoAI protects against dyslipidemia-induced dermatitis and atherosclerosis without affecting HDL.
J Lipid Res
; 56(3): 635-643, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25593328
6.
Proprotein convertase subtilisin kexin type 9 promotes intestinal overproduction of triglyceride-rich apolipoprotein B lipoproteins through both low-density lipoprotein receptor-dependent and -independent mechanisms.
Circulation
; 130(5): 431-41, 2014 Jul 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-25070550
7.
Response by Mueller et al to Letter Regarding Article, "Deletion of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Accelerates Atherosclerosis Regression and Increases C-C Chemokine Receptor Type 7 (CCR7) Expression in Plaque Macrophages".
Circulation
; 139(16): 1983-1984, 2019 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30986111
8.
Loss of plasma proprotein convertase subtilisin/kexin 9 (PCSK9) after lipoprotein apheresis.
Circ Res
; 113(12): 1290-5, 2013 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-24122718
9.
Macrophage-derived apoESendai suppresses atherosclerosis while causing lipoprotein glomerulopathy in hyperlipidemic mice.
J Lipid Res
; 55(10): 2073-81, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25183802
10.
Response to letter regarding article, "Proprotein convertase subtilisin kexin type 9 promotes intestinal overproduction of triglyceride-rich apolipoprotein B lipoproteins through both low-density lipoprotein receptor-dependent and -independent mechanisms".
Circulation
; 131(18): e428, 2015 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-25940973
11.
Response to Duell et al.
Circ Res
; 115(1): e5, 2014 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-24951770
12.
Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms.
Cardiovasc Res
; 110(2): 268-78, 2016 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26980204
13.
New developments in atherosclerosis: clinical potential of PCSK9 inhibition.
Vasc Health Risk Manag
; 11: 493-501, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26345307
14.
PCSK9 inhibition to reduce cardiovascular disease risk: recent findings from the biology of PCSK9.
Curr Opin Endocrinol Diabetes Obes
; 22(2): 126-32, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25692926